Analysis of a murine Pink1 deficiency in serotonergic and dopaminergic neurons in respect of Parkinson´s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Ludwig-Maximilians-Universität, Dissertation, 2018
- Keyword
-
Dopaminergic neurons
Mice
Scarcity
Testing
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (when)
-
2018
- Creator
-
Hummel, Angelika
- Contributor
-
Vogt Weisenhorn, Daniela
- URN
-
urn:nbn:de:bvb:19-223740
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hummel, Angelika
- Vogt Weisenhorn, Daniela
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Time of origin
- 2018
Other Objects (12)
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
The Parkinson’s disease-related kinase Pink1 mediates mitochondrial quality control
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Molecular characterisation of SGCE-associated myoclonus-dystonia and PINK1-associated Parkinson';s disease
The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
Parkinson's disease: PINK1, PARKIN and stress signaling to mitochondria
The mitochondrial kinase PINK1, stress response and Parkinson's disease
Analysis of systemic and cellular functions of the Parkinson`s disease related gene Pink1
Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
The role of PINK1 in the pathoethiology of Parkinson's disease
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
The Parkinson’s disease-related kinase Pink1 mediates mitochondrial quality control
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Molecular characterisation of SGCE-associated myoclonus-dystonia and PINK1-associated Parkinson';s disease
The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
Parkinson's disease: PINK1, PARKIN and stress signaling to mitochondria
The mitochondrial kinase PINK1, stress response and Parkinson's disease
Analysis of systemic and cellular functions of the Parkinson`s disease related gene Pink1
Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
The role of PINK1 in the pathoethiology of Parkinson's disease
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
The Parkinson’s disease-related kinase Pink1 mediates mitochondrial quality control
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Molecular characterisation of SGCE-associated myoclonus-dystonia and PINK1-associated Parkinson';s disease
The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
Parkinson's disease: PINK1, PARKIN and stress signaling to mitochondria
The mitochondrial kinase PINK1, stress response and Parkinson's disease
Analysis of systemic and cellular functions of the Parkinson`s disease related gene Pink1
Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?